Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazepam on Blood Pressure Regulation
NCT05069779Phase 1Completed
- Sponsor
- University of Brasília
- Start
- Aug 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of diazepam in anxiety disorder, sponsored by University of Brasília. Primary endpoints: Resting beat-to-beat blood pressure variability and Systolic and diastolic blood pressure. Started Aug 2017; status: completed.
02
Drugs
diazepam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT05069779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05069779.